Stock market week-in-review for 5 large GI companies — July 17-21

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of July 17 to July 21.

Advertisement

Note: This data was compiled using Google Finance.

1. Allergan Pharmaceuticals

Opened: $247.19 on July 17
Peaked: $251.71 on July 21
Closed: $250.96 on July 21
Percent change between July 17 and July 21: 1.53 percent

2. Exact Sciences Corp.

Opened: $38.97 on July 17
Peaked: $39.59 on July 20
Closed: $39.17 on July 21
Percent change between July 17 and July 21: 0.51 percent

3. Johnson & Johnson

Opened: $132.64 on July 17
Peaked: $137.05 on July 20
Closed: $135.37 on July 21
Percent change between July 17 and July 21: 2.06 percent

4. Synergy Pharmaceuticals

Opened: $4.47 on July 17
Peaked: $4.48 on July 17
Closed: $4.26 on July 24
Percent change between July 17 and July 21: -4.69 percent

5. Valeant Pharmaceuticals

Opened: $17.23 on July 17
Peaked: $17.73 on July 20
Closed: $17.50 on July 21
Percent change between July 17 and July 21: 1.5 percent

More articles on gastroenterology:
GI leader to know: Dr. George Zahrebelski of Digestive Disorder & Liver Center
5 new GI-driven ASCs & facilities — June 2017
GI center to know: IndyGastro

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.